Evonik will invest a low double-digit million Euro amount to upgrade its European methionine facilities, aiming to improve process efficiency and sustainability. The work will require a partial shutdown for 8–10 weeks between May and July 2025.

Evonik is continuing to optimize its global production setup for MetAMINO® (DL-methionine) with a technical upgrade of its European methionine Verbund Antwerp (Belgium)/Wesseling (Germany). The low double-digit million euro investment requires a partial shutdown of these facilities for 8-10 weeks in the period May to July 2025. All existing contracts and supply agreements will be honored.

Dr. Dirk Hoehler

“We are constantly working to further increase the process efficiency, reliability and sustainability of our three global methionine production hubs. This is how we remain competitive and ensure highest possible supply security for our customers,” said Dr. Dirk Hoehler, head of the amino acids business of Evonik’s Animal Nutrition business line.

Measures to increase process efficiency and reliability include a new process control system and a new bagging station. 

Evonik is the only global player in methionine that serves growing global feed markets from three world-scale production hubs in three regions of the world: Antwerp/Wesseling, Mobile (Alabama, USA), and Singapore. In the last three years, the company has invested over €200 million in expanding its methionine facilities in Singapore and in the backward integration of methionine production in Mobile.